Meribank Biotech Co., Ltd (TPEX:4724)
Taiwan · Delayed Price · Currency is TWD 13.85
+0.70 (5.32%)
Apr 20, 2026, 1:10 PM CST
Meribank Biotech Market Cap
Meribank Biotech has a market cap or net worth of 1.29 billion as of April 20, 2026. Its market cap has decreased by -14.83% in one year.
Market Cap
1.29B
Enterprise Value
2.19B
Revenue
471.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.85
Market Cap Chart
Since June 16, 2023, Meribank Biotech's market cap has decreased from 1.95B to 1.29B, a decrease of -33.77%. That is a compound annual growth rate of -13.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 1.16B | -19.57% |
| Dec 31, 2025 | 1.44B | -41.61% |
| Dec 31, 2024 | 2.46B | 2.99% |
| Dec 29, 2023 | 2.39B | 22.90% |
| Jun 16, 2023 | 1.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.40B |
| Abnova (Taiwan) | 1.36B |
| Enimmune | 1.34B |
| Great Novel Therapeutics Biotech & Medicals | 1.33B |
| Holy Stone Healthcare | 1.24B |
| GeneReach Biotechnology | 1.13B |
| Taiwan Advance Bio-Pharmaceutical | 1.13B |
| Level Biotechnology | 1.09B |